EA023239B1 - Соединения в качестве ингибиторов диацилглицерин ацилтрансферазы - Google Patents

Соединения в качестве ингибиторов диацилглицерин ацилтрансферазы Download PDF

Info

Publication number
EA023239B1
EA023239B1 EA201391724A EA201391724A EA023239B1 EA 023239 B1 EA023239 B1 EA 023239B1 EA 201391724 A EA201391724 A EA 201391724A EA 201391724 A EA201391724 A EA 201391724A EA 023239 B1 EA023239 B1 EA 023239B1
Authority
EA
Eurasian Patent Office
Prior art keywords
phenyl
amino
acetic acid
oxo
carbamoyl
Prior art date
Application number
EA201391724A
Other languages
English (en)
Russian (ru)
Other versions
EA201391724A1 (ru
Inventor
Дунхой Цинь
Хемант Джоши
Рагхурам Тангирала
Зигфрид Бенджамин Кристенсен IV
Original Assignee
Глэксосмитклайн Интеллекчуал Проперти (No.2) Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47217644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA023239(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Глэксосмитклайн Интеллекчуал Проперти (No.2) Лимитед filed Critical Глэксосмитклайн Интеллекчуал Проперти (No.2) Лимитед
Publication of EA201391724A1 publication Critical patent/EA201391724A1/ru
Publication of EA023239B1 publication Critical patent/EA023239B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA201391724A 2011-05-20 2012-05-18 Соединения в качестве ингибиторов диацилглицерин ацилтрансферазы EA023239B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1451DE2011 2011-05-20
US201161495049P 2011-06-09 2011-06-09
PCT/US2012/038520 WO2012162127A1 (en) 2011-05-20 2012-05-18 Novel compounds as diacylglycerol acyltransferase inhibitors

Publications (2)

Publication Number Publication Date
EA201391724A1 EA201391724A1 (ru) 2014-04-30
EA023239B1 true EA023239B1 (ru) 2016-05-31

Family

ID=47217644

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391724A EA023239B1 (ru) 2011-05-20 2012-05-18 Соединения в качестве ингибиторов диацилглицерин ацилтрансферазы

Country Status (20)

Country Link
US (1) US9242929B2 (https=)
EP (1) EP2723332B1 (https=)
JP (1) JP5893724B2 (https=)
KR (1) KR20140033426A (https=)
CN (1) CN103687595B (https=)
AU (1) AU2012259042B2 (https=)
CA (1) CA2836666A1 (https=)
CO (1) CO6811853A2 (https=)
CR (1) CR20130603A (https=)
DO (1) DOP2013000273A (https=)
EA (1) EA023239B1 (https=)
ES (1) ES2572261T3 (https=)
IL (1) IL229487A0 (https=)
MA (1) MA35398B1 (https=)
MX (1) MX2013013565A (https=)
PE (1) PE20140618A1 (https=)
PH (1) PH12013502403A1 (https=)
SG (1) SG194976A1 (https=)
WO (1) WO2012162127A1 (https=)
ZA (1) ZA201308569B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013341115B2 (en) * 2012-11-09 2016-07-14 Glaxosmithkline Llc Novel compounds as diacylglycerol acyltransferase inhibitors
WO2014081995A1 (en) * 2012-11-23 2014-05-30 Glaxosmithkline Llc Novel compounds as diacylglycerol acyltransferase inhibitors
WO2022026380A1 (en) * 2020-07-29 2022-02-03 Board Of Regents, The University Of Texas System Urea inhibitors of micro-rna
CN111747876B (zh) * 2020-08-03 2023-05-26 万华化学集团股份有限公司 一种氧化角黄素制备虾青素的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070249620A1 (en) * 2004-07-02 2007-10-25 Hitoshi Kurata Urea Derivative
US20100041590A1 (en) * 2006-12-21 2010-02-18 Anne Marie Jeanne Bouillot Compounds
WO2011080718A1 (en) * 2009-12-31 2011-07-07 Piramal Life Sciences Limited Inhibitors of diacylglycerol acyl transferase
US20110245247A1 (en) * 2010-03-30 2011-10-06 Abbott Gmbh & Co. Kg Novel small molecule potentiators of metabotropic glutamate receptors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006045209A (ja) * 2004-07-02 2006-02-16 Sankyo Co Ltd ウレア誘導体
KR20080000652A (ko) * 2005-04-19 2008-01-02 바이엘 파마슈티칼스 코포레이션 아릴 알킬산 유도체 및 그의 용도
EP2402320A1 (en) 2006-03-31 2012-01-04 Novartis AG Anorectic agents
WO2008099221A1 (en) * 2007-02-15 2008-08-21 Prosidion Limited Amide and urea derivatives for the treatment of metabolic diseases
JP2008255024A (ja) * 2007-04-02 2008-10-23 Banyu Pharmaceut Co Ltd ビアリールアミン誘導体
US8394823B2 (en) * 2008-04-11 2013-03-12 Bristol-Myers Squibb Company Triazolopyridine compounds useful as DGAT1 inhibitors
CA2790390A1 (en) 2009-08-28 2011-03-03 Daiichi Sankyo Company, Limited Novel tetrahydroisoquinoline compounds
JP2011088889A (ja) * 2009-09-24 2011-05-06 Daiichi Sankyo Co Ltd 新規テトラヒドロイソキノリン誘導体を含有する医薬

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070249620A1 (en) * 2004-07-02 2007-10-25 Hitoshi Kurata Urea Derivative
US20100041590A1 (en) * 2006-12-21 2010-02-18 Anne Marie Jeanne Bouillot Compounds
WO2011080718A1 (en) * 2009-12-31 2011-07-07 Piramal Life Sciences Limited Inhibitors of diacylglycerol acyl transferase
US20110245247A1 (en) * 2010-03-30 2011-10-06 Abbott Gmbh & Co. Kg Novel small molecule potentiators of metabotropic glutamate receptors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CURTIN et al. Isoindolinone ureas a novel class of KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 14 (2004) Pgs 4505-4509 entire document *

Also Published As

Publication number Publication date
CN103687595A (zh) 2014-03-26
EP2723332A1 (en) 2014-04-30
US9242929B2 (en) 2016-01-26
EP2723332B1 (en) 2016-03-02
ES2572261T3 (es) 2016-05-31
DOP2013000273A (es) 2014-04-15
CN103687595B (zh) 2017-05-24
KR20140033426A (ko) 2014-03-18
WO2012162127A1 (en) 2012-11-29
US20150307445A1 (en) 2015-10-29
PH12013502403A1 (en) 2018-04-11
CO6811853A2 (es) 2013-12-16
PE20140618A1 (es) 2014-06-05
SG194976A1 (en) 2013-12-30
JP5893724B2 (ja) 2016-03-23
JP2014525895A (ja) 2014-10-02
MA35398B1 (fr) 2014-09-01
CR20130603A (es) 2014-09-09
CA2836666A1 (en) 2012-11-29
AU2012259042A1 (en) 2013-04-18
MX2013013565A (es) 2014-01-08
ZA201308569B (en) 2014-07-30
EP2723332A4 (en) 2014-10-15
IL229487A0 (en) 2014-01-30
AU2012259042B2 (en) 2015-06-11
EA201391724A1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
US9879031B2 (en) Compounds as diacylglycerol acyltransferase inhibitors
WO2020051099A1 (en) Carboxamide and sulfonamide derivatives useful as tead modulators
TW202026271A (zh) 小分子pd-1/pd-l1抑制劑、其與pd-l1抗體的藥物組合物及其應用
JP2022527892A (ja) 小分子ｐｄ－１／ｐｄ－ｌ１阻害剤、ｐｄ－ｌ１抗体との医薬組成物及びその使用
EA023239B1 (ru) Соединения в качестве ингибиторов диацилглицерин ацилтрансферазы
US9624174B2 (en) Compounds as diacylglycerol acyltransferase inhibitors
AU2015247575C1 (en) Polycyclic hERG activators
CA3090829C (en) Urea-substituted aromatic ring-linked dioxinoquinoline compounds, preparation method and uses thereof
WO2014081995A1 (en) Novel compounds as diacylglycerol acyltransferase inhibitors

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU